Sun Pharma — Pharma Giant Shines Brighter 💊

climbed 1.2% to ₹1,831, marking a fresh breakout above prior resistance. The stock continues to lead the pharma pack with strong momentum and rising RSI strength. Technical View: Breakout confirmed above ₹1,820 with healthy volume support. RSI (14) at 79.4, indicating strong bullish momentum; slight overbought condition, but trend remains strong. EMA-9 support at ₹1,790 acts as a near-term safety zone. Support: ₹1,790 | Resistance: ₹1,860–₹1,880 | Bias: Strongly bullish. Fundamental View: Continued market share gains in specialty and US formulations. Solid pipeline of new launches and R&D momentum driving medium-term growth. Robust balance sheet and operating leverage sustaining earnings trajectory. Outlook: Momentum trend intact. As long as price sustains above ₹1,790, Sun Pharma may target ₹1,880+ in short term.